C
Cresco Labs
Enhancing the lives of Illinois medical cannabis patients and inciting the progressive evolution of the medical cannabis industry
About Cresco Labs
Cresco Labs is a prominent player in the U.S. cannabis industry, known for its comprehensive approach to the market. The company operates as a grower, processor, and retailer of premium cannabis products, serving both recreational users and medical patients. Cresco Labs is publicly traded under the ticker symbols CSE: CL and OTCQX: CRLBF, which means its shares are available for public investment.
Read full description
Cresco Labs targets a broad spectrum of consumers, from those who are well-versed in cannabis to newcomers. The company’s portfolio includes a variety of trusted brands designed to meet different consumer needs, ensuring a consistent and high-quality experience. This approach allows Cresco to cater to diverse lifestyles and preferences, giving consumers the control and reliability they seek.
Operating in eleven states, Cresco Labs focuses on markets with high demand and stringent regulations, which act as barriers to entry for competitors. This strategic focus allows the company to capitalize on significant growth opportunities while maintaining a competitive edge. Cresco Labs emphasizes shared value, meaning that its success translates into benefits for its stakeholders, including local communities and the broader industry.
The company is committed to responsible industry practices, exceeding regulatory requirements to set higher standards. This includes collaborating with local governments to establish appropriate regulations, designing eco-friendly packaging, and supporting community empowerment and education initiatives. Cresco Labs aims to build an industry that is both reputable and enjoyable for all participants.
Cresco Labs generates revenue through the cultivation, manufacturing, and retailing of cannabis products. Its state-of-the-art facilities and expert team ensure the delivery of top-tier products, whether for recreational enjoyment or medical relief. By maintaining high standards and focusing on quality, Cresco Labs continues to grow its market presence and consumer trust.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Chicago, United States
- Listing
- IPO 2018
- Employees
- 1,289
- Open positions
- 39
- Dealroom signal
- 68.1/100
- Industry
- Health, Food
- Sub-industry
- BioTechnology, Innovative Food
- Sector
- Biotech & Life Sciences, Wholesale, Retail, Biotechnology, Cannabis, Novel Farming, Biotech and Pharma, Hard Tech, Quasi tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 7 companies, latest Mar 2022
- Capital deployed
- —
- Preferred round
- ACQUISITION
Latest news
Press, funding announcements and product moves mentioning Cresco Labs.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Jun 2026 | $50M | — | Needham Bank | ↗ |
| POST IPO DEBTDebt | Aug 2025 | $325M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $654M | -0.2% | $143M | 21.9% |
| 2025 | $656M | -9.5% | $145M | 22.1% |
| 2024 | $724M | -6% | $116M | 16% |
| 2023 | $771M | -8.5% | $135M | 17.6% |
| 2022 | $843M | +2.6% | $123M | 14.7% |
| 2021 | $822M | +72.5% | $133M | 16.2% |
| 2020 | $476M | — | $98M | 20.6% |
Growth signals
Latest recorded traffic for Cresco Labs is 29K monthly website visits, down 37% over the last three months. Cresco Labs's team grew 2.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
CannabistNew York City, United StatesPatient-center healthcare company setting th standard of care for medical marijuana
$444Mvaluation
Laurel Harvest LabsMontgomery Township, United StatesLAUREL HARVEST IS CLOSED 1/1/22
$80Mvaluation
Cure PennsylvaniaPhoenixville, United StatesHome - Cure Pennsylvania | Medical Marijuana | Patient Consultation
$90Mvaluation
CultivateUnited StatesCultivate | The Premier Cannabis Dispensary in Mass
→
Blair Wellness CenterBaltimore, United StatesBlair Wellness Center Medical Marijuana Dispensary | Baltimore City
→
Bluma WellnessFort Lauderdale, United StatesAiming to cultivate a remarkable experience through exceptional cannabis
→
Hope Heal HealthFall River, United StatesHelping to unlock all the benefits the cannabis plant can provide
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Erecruit
Series B and later2 investors entered at this stage
BAM Elevate
Needham Bank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cresco Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cresco Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







